Institutional investors control 26.95% of the outstanding shares in BLRX. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Other industry. Additionally, during the quarter ended March 2019, these large investors purchased a net $2.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SABBY CAPITAL LLC Bought 1.1 Million shares of BioLine RX Ltd
ARMISTICE CAPITAL LLC Bought 1.0 Million shares of BioLine RX Ltd